ArticleFrontiers in oncology2026

Impact of HER2 immunohistochemistry score on pathological complete response and survival in HER2-positive breast cancer treated with neoadjuvant therapy: differential outcomes by hormone receptor status.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.